Hantech Bio-Technology Co., Ltd. (1294.TWO)
TWD 89.5
(0.56%)
TWD 89.5
(0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 191.9 Million | 63.17 Million | 44.38 Million | 110.83 Million | - |
| Net Income | 184.56 Million | 57.72 Million | 38.41 Million | 69.97 Million | - |
| Depreciation & Amortization | 20.94 Million | 19.32 Million | 18.7 Million | 14.69 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 53 Thousand | 174 Thousand | 4.21 Million | 7.56 Million | - |
| Change in working capital | 2.24 Million | -12.7 Million | 4.55 Million | 18.73 Million | - |
| Other non-cash items | 1.21 Million | 1.1 Million | 1.29 Million | 984 Thousand | - |
| Investing Cash Flow | -295.62 Million | -84.07 Million | -79.76 Million | -103.22 Million | - |
| Investments in PPE | -297.22 Million | -83.61 Million | -80.31 Million | -103.92 Million | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -1.2 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 963 Thousand | -572 Thousand | 555 Thousand | 695 Thousand | - |
| Financing Cash Flow | 195.82 Million | 9.52 Million | 40.4 Million | 54.23 Million | - |
| Debt repayment | -217.9 Million | -27.62 Million | -52.52 Million | -57.97 Million | - |
| Dividends payments | -16.84 Million | - | -8.05 Million | -3.71 Million | -3.71 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 2.06 Million | 44.62 Million | 3.17 Million | - | - |
| Other Financing Activities | -7.3 Million | - | - | 4.9 Million | -60 Thousand |
| Accounts receivables | -38.01 Million | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -50.08 Million | -9.72 Million | 1.45 Million | -6.36 Million | - |
| Other working capital | 90.34 Million | - | - | - | - |
| Cash at beginning of period | 75.04 Million | 86.41 Million | 81.78 Million | 20.17 Million | - |
| Cash at end of period | 167.09 Million | 75.04 Million | 86.41 Million | 81.78 Million | - |
| Capital Expenditure | -297.22 Million | -83.61 Million | -80.31 Million | -103.92 Million | - |
| Effect of forex changes on cash | -54 Thousand | 4000.00 | -399 Thousand | -229 Thousand | - |
| Net cash flow / Change in cash | 92.05 Million | -11.37 Million | 4.63 Million | 61.61 Million | - |
| Free Cash Flow | -105.31 Million | -20.43 Million | -35.92 Million | 6.91 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 59.98 Million | 44.47 Million | 184.56 Million | 51.93 Million | 11.44 Million | 57.72 Million |
| Depreciation & Amortization | 8.23 Million | 8.03 Million | 20.94 Million | 5.05 Million | 5.05 Million | 19.32 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 48 Thousand | 28 Thousand | 53 Thousand | 30 Thousand | -54 Thousand | 174 Thousand |
| Change in working capital | -12.28 Million | -43.97 Million | 2.24 Million | 8.98 Million | 10.63 Million | -12.7 Million |
| Other non-cash items | 1.12 Million | 1.2 Million | 1.21 Million | 84 Thousand | 240 Thousand | 1.1 Million |
| Investing Cash Flow | -11.73 Million | -6.74 Million | -295.62 Million | -7.6 Million | -25.28 Million | -84.07 Million |
| Investments in PPE | -2.59 Million | -6.74 Million | -297.22 Million | -7.81 Million | -26.63 Million | -83.61 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -1.2 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 8000.00 | 1000.00 | 963 Thousand | 1.11 Million | -160 Thousand | -572 Thousand |
| Financing Cash Flow | -6.11 Million | -30.47 Million | 195.82 Million | -25.43 Million | 36.16 Million | 9.52 Million |
| Debt repayment | -4.36 Million | -29.36 Million | -217.9 Million | -23.55 Million | -36.02 Million | -27.62 Million |
| Dividends payments | - | - | -16.84 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1000.00 | 641 Thousand | 2.06 Million | - | 2.06 Million | 44.62 Million |
| Other Financing Activities | 1000.00 | - | - | - | - | - |
| Accounts receivables | -24.43 Million | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -20.46 Million | -5.58 Million | -50.08 Million | -1.19 Million | -12.18 Million | -9.72 Million |
| Other working capital | 17.55 Million | - | - | - | - | - |
| Cash at beginning of period | 139.45 Million | 167.09 Million | 75.04 Million | 113.02 Million | 75.04 Million | 86.41 Million |
| Cash at end of period | 149.46 Million | 139.45 Million | 167.09 Million | 137.39 Million | 113.02 Million | 75.04 Million |
| Capital Expenditure | -2.59 Million | -6.74 Million | -297.22 Million | -7.81 Million | -26.63 Million | -83.61 Million |
| Effect of forex changes on cash | 152 Thousand | 295 Thousand | -54 Thousand | 112 Thousand | -31 Thousand | 4000.00 |
| Net cash flow / Change in cash | 10 Million | -27.63 Million | 92.05 Million | 24.36 Million | 37.98 Million | -11.37 Million |
| Free Cash Flow | 25.1 Million | 2.54 Million | -105.31 Million | 49.47 Million | 506 Thousand | -20.43 Million |
CORBF
2130
6086
META
INAI
600228